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Introduction
============

Acute respiratory distress syndrome (ARDS) is a syndrome with various etiologies characterized by lung inflammation, increased permeability, pulmonary edema, hypoxemia, and decreased lung compliance \[[@REF1]\]. Clinical hallmarks of ARDS are hypoxemia and bilateral radiographic opacities, while the pathological hallmark is diffuse alveolar damage \[[@REF1]\]. The clinical features of ARDS usually appear within 6 to 72 hours of an inciting event and worsen rapidly \[[@REF1]\]. In a cohort study by Cheung et al., researchers attempted to determine the long-term outcomes of survivors of ARDS and it was determined that ARDS survivors continue to have a functional impairment and compromised health-related quality of life 2 years after discharge from the ICU \[[@REF2]\]. Furthermore, patients who require mechanical ventilation in ARDS have a higher severity of illness and a higher number of comorbidities than their non-mechanically ventilated counterparts \[[@REF3]\]. These patients also have higher lengths of stay, thus driving up total costs regardless of stable daily costs after the first two days \[[@REF4]-[@REF5]\]. Given the high cost of ARDS management and its life-threatening implications, it is of utmost importance to explore the causes and predictors of 30-day readmission in ARDS patients. These are currently unknown to the US population. The objective of this study was to identify the 30-day readmission rates and modifiable predictors of 30-day readmission in ARDS patients using the largest publicly available nationwide database from the US.

Materials and methods
=====================

Data source

Our retrospective observational study was derived from the subset of the Healthcare Cost and Utilization Project (HCUP) sponsored by the Agency for Healthcare Research and Quality (AHRQ) \[[@REF6]\]. The National Readmission Database (NRD) is one of the largest publicly available all-payer inpatient care databases in the United States, including data on approximately 14 million discharges in the year 2013, estimating roughly 36 million weighted discharges from 21 states with reliable, verified linkage numbers \[[@REF6]-[@REF7]\]. NRD represents 49% of total US hospitalizations \[[@REF7]\]. Patients were tracked using variable "NRD_Visitlink" used to verify patient linkage number for linking hospital visits for the same patient across hospitals and time between two admissions was calculated by subtracting time variable "NRD_DaysToEvent." Time to readmission was calculated by subtracting the length of stay (LOS) of primary admissions to time between 2 admissions \[[@REF8]-[@REF9]\]. National estimates are produced using sampling weights provided by the NRD. The details regarding the NRD data are available online \[[@REF7]-[@REF8]\].

Study population and design

All variables were identified using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) Volume 3 diagnosis codes. We queried the NRD database using the presence of ICD-9-CM diagnosis code of 518.82 for ARDS in primary or secondary diagnostic fields which only includes ARDS related to non-trauma or surgical causes. We identified 24,307 ARDS patients (weighted N= 53,555) after excluding patients with missing data for age or gender. We also excluded procedures done in the month of December, as we did not have follow-up data for the same, data points with LOS of 0 days were also excluded. Figure [1](#FIG1){ref-type="fig"} shows the sequential derivation of the study cohort. Patients who were readmitted to the hospital within 30 days within the same calendar year were further evaluated.

Outcome variables

The primary outcome was 30-day readmission rate. Secondary outcomes included predictors of readmission in ARDS patients. NRD variables were used to identify patients' demographic characteristics including age, gender, hospital characteristics such as bed size and teaching status, and other patient-specific characteristics including median household income category for patient's zip code, primary payer, admission type, admission day, and discharge disposition \[[@REF8]\]. We identified various co-morbid conditions as it is provided by AHRQ co-morbidity (cm\_) measures with the database. Additionally, Deyo's modification of the Charlson comorbidity index (CCI) was used to define the severity of co-morbid conditions \[[@REF10]-[@REF12]\]. Deyo modification of Charlson co-morbidity index (CCI), which contains 17 co-morbid conditions was used as a measure of co-morbidity burden \[[@REF10]\]. With score ranges from zero to 33, a higher score means a greater burden of co-morbid diseases \[[@REF10]\].

Statistical analysis

We utilized Statistical Analysis Software (SAS) 9.4 (SAS Institute, Cary, NC, USA) for all analyses. Survey procedures were implemented to adjust for stratified cluster design of NRD with DOMAIN, STRATA, CLUSTER, and WEIGHT statements \[[@REF13]\]. We used the *X*^2^ test for categorical variables, t-test for normally distributed continuous variables, and the Wilcoxon rank-sum test for non-normally distributed continuous variables to compare the baseline characteristics of the study population. P-values less than 0.05 were considered significant. The independent predictors of unplanned 30-day readmission were identified by multivariate logistic regression adjusting for stratified cluster design of NRD. Multivariate models for readmission included hospital-level variables such as age, gender, admission type (elective vs. non-elective), median household income (higher income quartile vs. lowest income quartile), the primary payer (private insurance vs. self-pay vs. Medicaid/Medicare). The multivariate model for readmission was run only on patients who survived index admission. All interactions were thoroughly tested. Few observations and response variables were deleted due to missing or invalid values for its explanatory, frequency, weight, strata, or cluster variables.

Results
=======

Readmission rate

There were 24,307 (weighted N = 53,555) index admissions for ARDS in the US during the study period out of which, 4,470 (weighted N = 9,807) patients were readmitted within 30 days, which inferred the readmission rate at 18% (Figure [1](#FIG1){ref-type="fig"}).
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Baseline characteristics of index admissions stratified by presence of 30-day readmission

Index admissions who were readmitted within 30-day had a significantly higher baseline burden of comorbidities with a CCI ≥1 (87% vs. 81%; *p* \< 0.001) as compared to those who did had 30-day readmission. Similarly, comorbidities like hypertension (63% vs 60%; *p* \< 0.001), electrolyte imbalance (50% vs 43%; *p* \< 0.001), renal failure (28% vs. 20%; *p* \< 0.001), and diabetes mellitus (27% vs 24%; *p* \< 0.001) were higher among those index admissions who had 30-day readmission. The index admissions that had readmission were more likely to be from large bed size hospital (67% vs. 64%; *p* \< 0.001), were admitted non-electively (93% vs. 90%; p \<0.001) and had Medicare as an insurance (67% vs. 63%; *p* \< 0.001). Additionally, an index admission with readmission had higher proportion of discharge disposition to facility (32% vs. 26%; *p* \< 0.001) and LOS ≥7 days (48% vs. 40%; *p* \< 0.001) than those without readmits. Other characteristics, including age, gender, and hospital teaching status were approximately evenly distributed among both groups. Another detailed distribution of patient and hospital-level characteristics has been depicted in Table [1](#TAB1){ref-type="table"}.

###### Baseline characteristics of index admissions stratified by presence of 30-day readmission

z - Charlson/Deyo co-morbidity index (CCI) was calculated as per Deyo classiﬁcation.

\* Variables are AHRQ co-morbidity (cm\_) measures.

x- Represents a quartile classiﬁcation of the estimated median household income of residents in the patient's ZIP Code, derived from ZIP Code-demographic data obtained from Claritas. The quartiles are identiﬁed by values of 1 to 4, indicating the poorest to wealthiest populations. Because these estimates are updated annually, the value ranges vary by year. <http://www.hcupus.ahrq.gov/db/vars/zipinc_qrtl/nisnote.jsp.>

\# -HMO: Health Maintenance Organization.

{- The bed size cutoff points divided into small, medium, and large have been done so that approximately one-thirdof the hospitals in a given region, location, and teaching status combination would fall within each bed size category. State and County QuickFacts. Washington, DC: US Census Bureau; 2012.

  -------------------------------------------------- ----------------- ---------------- ------------- ---------
                                                     Index Admission   No Readmission   Readmission   p value
  Total population (unweighted)                      24,307            19,837           4,470          
  Total population (weighted)                        53,555            43,748           9,807          
  Patient level variables                                                                              
  Age (%)                                                                                             0.08
  ≥85                                                14                14               13             
  65-84                                              29                29               30             
  45-64                                              39                40               40             
  18-44                                              16                17               17             
  Gender (%)                                                                                          0.09
  Female                                             52                53               52             
  Male                                               47                47               48             
  CCI^z^ (%)                                                                                          .001
  0                                                  18                19               13             
  1-3                                                56                56               53             
  4-6                                                19                18               26             
  7-9                                                5                 5                7              
  10-12                                              1                 1                1              
  13-15                                              0.05              0.05             0.05           
  ≥16                                                0.06              0.00             0.01           
  Length of stay (%)                                                                                  .001
  1-3                                                29                31               25             
  4-6                                                28                28               26             
  7-9                                                16                16               17             
  10-12                                              8                 8                9              
  13-15                                              5                 5                7              
  ≥16                                                12                11               15             
  Comorbidities (%) \*                                                                                 
  Drug abuse                                         4                 4                5             0.08
  Hypertension                                       61                60               63            .001
  Hypothyroidism                                     15                15               16            0.004
  Liver disease                                      4                 4                5             .001
  Fluid and electrolyte disorders                    44                43               50            .001
  Metastatic cancer                                  4                 3                5             0.003
  Neurological disorders                             12                12               13            0.12
  Obesity                                            16                17               15            0.07
  Peripheral vascular disorders                      8                 8                10            .001
  Psychoses                                          5                 5                7             0.001
  Pulmonary circulation disorders                    5                 6                6             0.3
  Renal Failure                                      22                20               28            .001
  Valvular disease                                   7                 7                8             0.28
  Alcohol abuse                                      5                 5                5             0.26
  Rheumatoid arthritis/ collagen vascular diseases   4                 4                4             0.58
  Chronic blood loss anemia                          1                 1                2             0.12
  Congestive heart failure                           18                17               22            .001
  Chronic pulmonary disease                          19                19               20            0.15
  Depression                                         13                13               13            0.99
  Diabetes, uncomplicated                            25                24               27            0.002
  Diabetes with chronic complications                7                 7                10            .001
  Median household income (%) ^x^                                                                     0.1
  76-100^th^                                         27                26               28             
  51-75^th^                                          26                26               24             
  26-50^th^                                          25                25               25             
  0-25^th^                                           21                22               21             
  Primary Payer (%)                                                                                   .001
  Self-pay/no charge/other                           63                63               67             
  Private including HMO^\#^                          11                10               13             
  Medicaid                                           18                19               15             
  Medicare                                           8                 8                5              
  Hospital bed size (%) ^{^                                                                           0.02
  Large                                              11                11               10             
  Medium                                             24                25               23             
  Small                                              65                64               67             
  Hospital teaching status (%)                                                                        0.05
  Non-metropolitan hospital                          32                32               32             
  Metropolitan teaching                              58                58               59             
  Metropolitan non-teaching                          10                10               9              
  Admission type (%)                                                                                   
  Elective                                           91                90               93             
  Non elective                                       9                 10               7              
  Disposition (%)                                                                                     .001
  Against medical advice                             50                52               42             
  Facilities                                         22                21               24             
  Home health care                                   27                26               32             
  Home                                               1                 1                2              
  -------------------------------------------------- ----------------- ---------------- ------------- ---------

Predictors of 30-day readmission

From our analysis, several predictors associated with increased 30-day readmission were higher CCI (OR for ≥3 1.147, 95%CI: 1.065-1.236; *p *\< 0.001), self-pay/no charge/other (OR 1.19, 95%CI: 1.02-1.38; *p *= 0.02), discharge disposition against medical advice (OR 1.25, 95%CI:1.12-1.39; *p *\< 0.001), and discharge disposition to facility (OR 1.28, 95%CI 1.15-1.43; *p *\< 0.001). Meanwhile, we also found several predictors associated with reduced odds for 30-day readmission: higher income class (OR 0.86, 95%CI:0.79-0.99; *p *= 0.03), private insurance (OR 0.81, 95% CI:0.67-0.94; *p *= 0.01), and teaching metropolitan hospital (OR 0.72, 95% CI:0.61-0.94; *p *= 0.01). On the other hand, several characteristics were not found to be associated with increased or decreased readmission (Table [2](#TAB2){ref-type="table"}).

###### Multivariate analysis in 30-day readmission in ARDS patients

z - Charlson/Deyo co-morbidity index (CCI) was calculated as per Deyo classiﬁcation.

 \*Variables are AHRQ co-morbidity (cm\_) measures.

x- Represents a quartile classiﬁcation of the estimated median household income of residents in the patient's ZIP Code, derived from ZIP Code-demographic data obtained from Claritas. The quartiles are identiﬁed by values of 1 to 4, indicating the poorest to wealthiest populations. Because these estimates are updated annually, the value ranges vary by year. <http://www.hcupus.ahrq.gov/db/vars/zipinc_qrtl/nisnote.jsp.>

 \# -HMO: Health Maintenance Organization. {- The bed size cutoff points divided into small, medium, and large have been done so that approximately one-third of the hospitals in a given region, location, and teaching status combination would fall within each bed size category. State and County QuickFacts. Washington, DC: US Census Bureau; 2012. 

ARDS, acute respiratory distress syndrome

  ------------------------------------- ------------ ------------ ---------
  Predictors                            Odds Ratio   95% CI       p value
  Age                                                              
  ≥85                                   0.97         0.81-1.15    0.67
  65-84                                 0.75         0.61-0.92    0.001
  45-64                                 0.69         0.55-0.88    0.0002
  18-44                                 Ref                        
  Gender                                                           
  Female                                0.96         0.88-1.05    0.43
  Male                                  Ref                        
  CCI^z^                                                           
  ≥16                                   1.29         1.14-1.46    .001
  13-15                                 1.39         1.14-1.70    .001
  10-12                                 1.24         0.87-1.76    0.23
  7-9                                   0.61         0.08-4.73    0.64
  4-6                                   1.98         0.14-28.82   0.62
  0-3                                   Ref                        
  Length of stay                                                   
  ≥16                                   1.16         1.03-1.31    0.01
  13-15                                 1.26         1.11-1.44    0.0003
  10-12                                 1.27         1.09-1.45    0.003
  7-9                                   1.51         1.26-1.78    .001
  4-6                                   1.39         1.19-1.62    .001
  1-3                                   Ref                        
  Comorbidities\*                                                  
  Drug abuse                            1.23         0.96-1.57    0.11
  Hypertension                          1.04         0.94-1.14    0.49
  Hypothyroidism                        1.14         1.02-1.27    0.02
  Liver disease                         1.19         0.99-1.42    0.06
  Fluid and electrolyte disorders       1.09         1.00-1.19    0.16
  Metastatic cancer                     1.09         0.85-1.38    0.3
  Neurological disorders                1.03         0.88-1.19    0.49
  Obesity                               1.01         0.89-1.14    0.73
  Peripheral vascular disorders         0.82         0.73-0.93    0.002
  Psychoses                             1.14         0.95-1.37    0.88
  Pulmonary circulation disorders       0.95         0.79-1.13    0.16
  Renal Failure                         1.15         1.00-1.29    0.54
  Peptic ulcer disease,                 3.99         1.30-12.38   0.01
  excluding bleeding                                               
  Valvular disease                      0.92         0.78-1.06    0.2
  Alcohol abuse                         0.99         0.79-1.12    0.21
  Rheumatoid arthritis/                 0.96         0.79-1.15    0.85
  collagen vascular diseases                                       
  Chronic blood loss anemia             1.18         0.88-1.57    0.65
  Congestive heart failure              1.13         1.01-1.25    0.27
  Chronic pulmonary disease             0.95         0.86-1.05    0.3
  Depression                            0.96         0.85-1.05    0.32
  Diabetes,                             1            0.91-1.10    0.71
  uncomplicated                                                    
  Diabetes with chronic complications   1.15         1.00-1.31    0.99
  Median household income ^x^                                      
  76-100^th^                            0.86         0.79-0.99    0.03
  51-75^th^                             0.97         0.86-1.09    0.62
  26-50^th^                             1.19         1.02-1.38    0.12
  0-25^th^                              Ref                        
  Primary Payer                                                    
  Self-pay/no charge/other              1.19         1.02-1.38    0.02
  Private including HMO^\#^             0.81         0.67-0.94    0.01
  Medicaid                              0.59         0.47-0.74    .001
  Medicare                              Ref                        
  Hospital bed size ^{^                                            
  Large                                 1.04         0.86-1.25    0.69
  Medium                                0.96         0.87-1.05    0.13
  Small                                 Ref                        
  Hospital teaching status                                         
  Non-metropolitan hospital             0.85         0.72-1.01    0.36
  Metropolitan teaching                 0.72         0.61-0.84    0.02
  Metropolitan non-teaching             Ref                        
  Admission type                                                   
  Elective                              0.72         0.61-0.84    .001
  Non elective                          Ref                        
  Admission day                                                    
  Weekend Admission                     0.98         0.88-1.09    0.69
  Weekday                               Ref                        
  Disposition                                                      
  Against medical advise                1.25         1.12-1.39    \<0.001
  Facilities                            1.28         1.15-1.43    \<0.001
  Home health care                      2.42         1.64-3.55    \<0.001
  Home                                  Ref                        
  ------------------------------------- ------------ ------------ ---------

Discussion
==========

We report contemporary data from an NRD on readmission of patients with ARDS. Our study reports an all-cause unplanned 30-day readmission rate of 18% in ARDS patients. A Canadian study on long-term outcomes of ARDS has an estimated 39% readmission in the first 2 years after the discharge \[[@REF2]\]. This study was from four academic tertiary care ICUs from a city \[[@REF2]\]. However, our study is based on a large administrative database, which can be weighted to produce national estimates. Our study also highlights that ARDS patients who got readmitted in 30 days had a higher burden of co-morbidities especially hypertension, electrolyte disorders, and diabetes. Pan et al. found that higher CCI is associated with the increased risk of admission which we have also repopulated in our study, CCI ≥3 (OR 1.147, 95%CI: 1.065-1.236; p\<0.001) \[[@REF14]\]. Furthermore, we found several other factors associated with increased 30-day readmission. We observed that patients who leave against medical advice showed a higher risk for unplanned 30-day readmission for ARDS. Furthermore, discharge to the facility was also a significant predictor of readmission in our study, which was also shown by Pan et al. \[[@REF14]\]. This could be because the patients being discharged to facilities are likely sicker with a higher number of co-morbidities or newly acquired morbidity or system failure due to the effect of ARDS \[[@REF15]\]. Further, we observed that self-pay/No charge/other had higher odds of unplanned 30-day readmission, and patients with the higher socioeconomic income class have the reduced odds of 30-day readmission, which signifies that socioeconomic factors might have played a role in leading to readmissions in the ARDS population. Meanwhile, Ferro EG et al. showed the percentage of readmissions was lower among the patients with private insurance in all-cause index hospitalizations \[[@REF16]\]. Interestingly, we also observed a similar phenomenon in ARDS index hospitalizations. It is known that Medicaid patients have greater difficulty obtaining appointments in comparison to privately insured patients \[[@REF17]\]. We postulate that privately insured patients have a better follow-up compared to others and hence, they had lower readmission rates in our study. We also found reduced odds of readmission in the patients at teaching metropolitan hospitals, which can be attributed to the advanced medical care and better implementation of the quality improvement programs in the academic settings. Khaksari BJ et al. showed no association between weekend admission and 30-day readmission, which was seen in our study as well \[[@REF18]\].

Our study has several limitations. First, our study is a retrospective study which makes it subjectable to selection bias. Secondly, the selection of samples relies on the sensitivity and specificity of ICD-9-CM codes which could have confounded our results. Also, the NRD database does not contain information on the long-term follow-up of the patients. Our study also lacks data on ARDS patients discharged to home hospice who are not at risk of being readmitted, which might result in an underestimation of the readmission rate. Despite its limitations, our study has several strengths. Our study is the first nationwide study looking at readmission rates and predictors of ARDS. Our sample size most closely represents the standardized U.S. population. Targets for future interventions should be focused on better risk stratification and controlling the predictors that aggravate the readmission rates of ARDS, which we were able to identify successfully.

Conclusions
===========

The unplanned 30-day readmission rates are higher for ARDS patients in the US. There are several modifiable factors such as type of insurance, socioeconomic status, and hospital type associated with 30-day readmission among ARDS patients. Further studies are needed to identify preventable readmissions, aim to modify the predictors, and develop a strategic approach to reduce the burden of readmissions in patients admitted with ARDS.
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